Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;21(8):e70604.
doi: 10.1002/alz.70604.

Fourteen years later: Reviewing the diagnostic criteria for behavioral-variant frontotemporal dementia

Affiliations

Fourteen years later: Reviewing the diagnostic criteria for behavioral-variant frontotemporal dementia

Olivier Piguet et al. Alzheimers Dement. 2025 Aug.

Abstract

Introduction: Diagnosis of behavioral-variant frontotemporal dementia (bvFTD) requires the presence of at least three of six core features. The contribution of each criterion toward diagnosis, however, remains unclear. We aimed to determine the frequency and combinations of diagnostic criteria at presentation and their contribution to survival.

Methods: Consecutive patients with a stable diagnosis of bvFTD between 2010 and 2023 were included. Demographic and cognitive data were also collected.

Results: A total of 110 patients were identified. Frequency of diagnostic criteria ranged from 89% (apathy; empathy loss) to 14.5% (dysexecutive profile), and 78 patients met at least four criteria. Mean survival time from symptom onset was 10.4 years and was not affected by the number and combination of core diagnostic criteria (P values ≥ 0.274).

Discussion: Our findings show that the requirements for the cognitive criterion are disproportionately restrictive, which may delay diagnosis and access to relevant treatments and therapies.

Highlights: The comparative usefulness of core criteria for frontotemporal dementia diagnosis is unclear. We identified the most common profiles of core features at baseline. Most common feature profiles included apathy and/or empathy loss. Feature profiles were not predictive of survival. Cognitive criterion appears overly restrictive in its current form.

Keywords: behavior; behavioral‐variant frontotemporal dementia; clinical presentation; cognition; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. Author disclosures are available in the supporting information.

Figures

FIGURE 1
FIGURE 1
Frequencies of core diagnostic criteria for behavioral‐variant frontotemporal dementia. Each bar represents the frequency (%) of the core diagnostic criteria at presentation
FIGURE 2
FIGURE 2
Frequencies of combinations of core diagnostic criteria for behavioral‐variant frontotemporal dementiain sporadic and genetic cases
FIGURE 3
FIGURE 3
Core cognitive criterion (F) with and without concurrent exclusion features (episodic memory disturbance; visuospatial disturbance) in patients diagnosed with behavioral‐variant frontotemporal dementia
FIGURE 4
FIGURE 4
Mean disease survival from disease onset in male and female patients diagnosed with behavioral‐variant frontotemporal dementia

References

    1. Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386:1672‐1682. doi: 10.1016/s0140-6736(15)00461-4 - DOI - PMC - PubMed
    1. van den Stock J, Bertoux M, Diehl‐Schmid J, et al. Current potential for clinical optimization of social cognition assessment for frontotemporal dementia and primary psychiatric disorders. Neuropsychol Rev. 2023;33:544‐550. doi: 10.1007/s11065-022-09554-3 - DOI - PubMed
    1. Ahmed RM, Hodges JR, Piguet O. Frontotemporal dementias: emerging milestones of the 21st century. Adv Exp Med Biol. 2021;1281:1‐15. doi: 10.1007/978-3-030-51140-1_1 - DOI - PubMed
    1. Piguet O, Kumfor F, Hodges JR. Diagnosing, monitoring and managing behavioural variant frontotemporal dementia. Med J Austral. 2017;207:303‐308. doi: 10.5694/mja16.01458 - DOI - PubMed
    1. Boeve BF, Boxer AL, Kumfor F, Pijnenburg Y, Rohrer JD. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 2022;21:258‐272. doi: 10.1016/s1474-4422(21)00341-0 - DOI - PubMed

LinkOut - more resources